Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0A9CZ
|
||||
| Former ID |
DNC014345
|
||||
| Drug Name |
PHASEOLLIDIN
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530829] | ||
| Formula |
C20H20O4
|
||||
| Canonical SMILES |
CC(=CCC1=C(C=CC2=C1OC3C2COC4=C3C=CC(=C4)O)O)C
|
||||
| InChI |
1S/C20H20O4/c1-11(2)3-5-14-17(22)8-7-13-16-10-23-18-9-12(21)4-6-15(18)20(16)24-19(13)14/h3-4,6-9,16,20-22H,5,10H2,1-2H3/t16-,20-/m0/s1
|
||||
| InChIKey |
OFWYIUYVHYPQNX-JXFKEZNVSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Neuraminidase | Target Info | Inhibitor | [530829] | |
| KEGG Pathway | Other glycan degradation | ||||
| References | |||||